D-202-2013 Class II Terminated

Recalled by Zydus Pharmaceuticals USA Inc — Pennington, NJ

FDA drug recall D-202-2013 was initiated by Zydus Pharmaceuticals USA Inc on Mar 5, 2013 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specifications: Pharmacist complaint of an excessive amount of broken and/or chipped tablets in the bottle. The recall status is terminated (terminated May 4, 2015). Affected quantity: 13,320 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 3, 2013
Initiation Date
Mar 5, 2013
Termination Date
May 4, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
13,320 bottles

Product description

Venlafaxine Hydrochloride Tablets, 75 mg*, 100-count tablets per bottle, Rx only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534, NDC 68382-021-01.

Reason for recall

Failed Tablet/Capsule Specifications: Pharmacist complaint of an excessive amount of broken and/or chipped tablets in the bottle.

Distribution pattern

Nationwide.

Code information

Lot #: MM8490, Exp 09/14

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-202-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-202-2013. Report a data issue: hello@regdatalab.com.